Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer
5505.0000 -30.00 (-0.54%)
NSE Dec 29, 2025 15:31 PM
Volume: 39,102
 

logo
Alkem Laboratories Ltd.
20 May 2023
5505.00
-0.54%
buy
by BOB Capital Markets Ltd.
Target: 3000
BOB Capital Markets Ltd.
Q4 EBITDA/PAT of Rs 3.5bn/Rs 710mn well short of consensus by 21%/ 79% primarily due to higher operating costs
 
Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Market closes lower, dragged down by foreign investor outflows and higher crude prices
Trendlyne Marketwatch | 29 Dec 2025, 04:01PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
| 02 Jul 2021